Dabrafenib in combination with trametinib for the treatment of metastatic melanoma. [electronic resource]
- Expert review of clinical pharmacology Jan 2015
- 25-33 p. digital
Publication Type: Journal Article; Review
1751-2441
10.1586/17512433.2015.974556 doi
Antineoplastic Combined Chemotherapy Protocols--therapeutic use Clinical Trials as Topic Humans Imidazoles--administration & dosage Melanoma--drug therapy Oximes--administration & dosage Protein Kinase Inhibitors--administration & dosage Pyridones--administration & dosage Pyrimidinones--administration & dosage Randomized Controlled Trials as Topic